These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20554461)

  • 21. Balloon-mounted stenting for ICAS in a multicenter registry study in China: a comparison with the WEAVE/WOVEN trial.
    Kang K; Zhang Y; Shuai J; Jiang C; Zhu Q; Chen K; Liu L; Li B; Shi X; Gao L; Liu Y; Wang F; Li Y; Liu T; Zheng H; Mo D; Gao F; Feng L; Wang Y; Wang Y; Miao Z; Ma N;
    J Neurointerv Surg; 2021 Oct; 13(10):894-899. PubMed ID: 33310785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated levels of pre-procedural high-sensitivity C-reactive protein is associated with midterm restenosis after extra- and intracranial stenting.
    Gupta R; Bhatt A; Kassab M; Majid A
    J Neuroimaging; 2010 Jan; 20(1):74-7. PubMed ID: 19021830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stent placement for atherosclerotic stenosis of the vertebral artery ostium: angiographic and clinical outcomes in 117 consecutive patients.
    Hatano T; Tsukahara T; Miyakoshi A; Arai D; Yamaguchi S; Murakami M
    Neurosurgery; 2011 Jan; 68(1):108-16; discussion 116. PubMed ID: 21099720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of high risk symptomatic intracranial atherosclerosis with balloon mounted coronary stents and Wingspan stents: single center experience over a 10 year period.
    Tarlov N; Jahan R; Saver JL; Sayre JW; Ali LK; Kim D; Duckwiler GR; Tateshima S; Viñuela F; Liebeskind DS
    J Neurointerv Surg; 2012 Jan; 4(1):34-9. PubMed ID: 21990460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors affecting in-stent restenosis after angioplasty with the Enterprise stent for intracranial atherosclerotic diseases.
    Zhang K; Li TX; Wang ZL; Gao BL; Gu JJ; Gao HL; Wang YF; Xia JC
    Sci Rep; 2021 May; 11(1):10479. PubMed ID: 34006896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of reoccurring instent restenosis following reintervention after stent-supported renal artery angioplasty.
    Zeller T; Sixt S; Rastan A; Schwarzwälder U; Müller C; Frank U; Bürgelin K; Schwarz T; Hauswald K; Brantner R; Noory E; Neumann FJ
    Catheter Cardiovasc Interv; 2007 Aug; 70(2):296-300. PubMed ID: 17630674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of intracranial in-stent restenosis using quantitative magnetic resonance angiography.
    Amin-Hanjani S; Alaraj A; Calderon-Arnulphi M; Aletich VA; Thulborn KR; Charbel FT
    Stroke; 2010 Nov; 41(11):2534-8. PubMed ID: 20930155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal treatment of renal artery in-stent restenosis: repeat stent placement versus angioplasty alone.
    N'Dandu ZM; Badawi RA; White CJ; Grise MA; Reilly JP; Jenkins JS; Collins TJ; Ramee SR
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):701-5. PubMed ID: 18360868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-stent restenosis after carotid angioplasty and stenting: a challenge for the vascular surgeon.
    Setacci C; de Donato G; Setacci F; Pieraccini M; Cappelli A; Trovato RA; Benevento D
    Eur J Vasc Endovasc Surg; 2005 Jun; 29(6):601-7. PubMed ID: 15878537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endovascular reconstruction by means of stent placement in symptomatic intracranial atherosclerotic stenosis.
    Lylyk P; Vila JF; Miranda C; Ferrario A; Musacchio A; Rüfenacht D; Cohen JE
    Neurol Res; 2005; 27 Suppl 1():S84-8. PubMed ID: 16197831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations.
    Magalhaes MA; Minha S; Chen F; Torguson R; Omar AF; Loh JP; Escarcega RO; Lipinski MJ; Baker NC; Kitabata H; Ota H; Suddath WO; Satler LF; Pichard AD; Waksman R
    Circ Cardiovasc Interv; 2014 Dec; 7(6):768-76. PubMed ID: 25466551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of patient age and stenosis location on wingspan in-stent restenosis.
    Turk AS; Levy EI; Albuquerque FC; Pride GL; Woo H; Welch BG; Niemann DB; Purdy PD; Aagaard-Kienitz B; Rasmussen PA; Hopkins LN; Masaryk TJ; McDougall CG; Fiorella D
    AJNR Am J Neuroradiol; 2008 Jan; 29(1):23-7. PubMed ID: 17989366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis.
    Habara S; Iwabuchi M; Inoue N; Nakamura S; Asano R; Nanto S; Hayashi Y; Shiode N; Saito S; Ikari Y; Kimura T; Hosokawa J; Nakamura M; Kotani J; Kozuma K; Mitsudo K
    Am Heart J; 2013 Sep; 166(3):527-33. PubMed ID: 24016503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Symptomatic ostial vertebral artery stenosis treated with tubular coronary stents: clinical results and restenosis analysis.
    Lin YH; Juang JM; Jeng JS; Yip PK; Kao HL
    J Endovasc Ther; 2004 Dec; 11(6):719-26. PubMed ID: 15615563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.
    Stone GW; Ellis SG; O'Shaughnessy CD; Martin SL; Satler L; McGarry T; Turco MA; Kereiakes DJ; Kelley L; Popma JJ; Russell ME;
    JAMA; 2006 Mar; 295(11):1253-63. PubMed ID: 16531618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
    Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factor impact on blood flow velocities and clinical outcomes of stented cervical and intracranial stenoses: preliminary observations.
    Moreira T; Michel P; Binaghi S; Hirt L
    Clin Neurol Neurosurg; 2012 Sep; 114(7):922-9. PubMed ID: 22402202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of symptomatic intracranial atherosclerotic stenosis with a normal-sized Gateway(™) balloon and Wingspan(™) stent.
    Yu J; Wang L; Deng JP; ; Gao L; Zhang T; Zhao ZW; Gao GD
    J Int Med Res; 2010; 38(6):1968-74. PubMed ID: 21227000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thirty-Day Outcome of a Multicenter Registry Study of Stenting for Symptomatic Intracranial Artery Stenosis in China.
    Miao Z; Zhang Y; Shuai J; Jiang C; Zhu Q; Chen K; Liu L; Li B; Shi X; Gao L; Liu Y; Wang F; Li Y; Liu T; Zheng H; Wang Y; Wang Y;
    Stroke; 2015 Oct; 46(10):2822-9. PubMed ID: 26286544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.